Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Stephen Waldo to Coronary Artery Disease

This is a "connection" page, showing publications Stephen Waldo has written about Coronary Artery Disease.

 
Connection Strength
 
 
 
11.174
 
  1. Kovach CP, Lipinski J, Mesenbring EC, Boulos P, Pribish A, Sola M, Glorioso TJ, Fearon WF, Yeh RW, Waldo SW. Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System. Circ Cardiovasc Interv. 2025 Mar; 18(3):e014899.
    View in: PubMed
    Score: 0.602
  2. Kovach CP, Valle JA, Waldo SW. Reply: Pitfalls of Simplifying the Original SYNTAX Score: A Temptation That Should Be?Resisted. JACC Cardiovasc Interv. 2023 04 24; 16(8):1004.
    View in: PubMed
    Score: 0.528
  3. Kovach CP, Hebbe A, Glorioso TJ, Barrett C, Bar?n AE, Mavromatis K, Valle JA, Waldo SW. Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 12 26; 15(24):2475-2486.
    View in: PubMed
    Score: 0.516
  4. Waldo SW, Glorioso TJ, Bar?n AE, Doll JA, Plomondon ME, Ho PM. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program. J Am Heart Assoc. 2022 02 15; 11(4):e024598.
    View in: PubMed
    Score: 0.486
  5. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2021 12; 14(12):e010863.
    View in: PubMed
    Score: 0.480
  6. Kovach CP, Hebbe A, Bar?n AE, Strobel A, Plomondon ME, Valle JA, Waldo SW. Clinical Characteristics and Outcomes Among Patients Undergoing High-Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2021 12 07; 10(23):e022131.
    View in: PubMed
    Score: 0.478
  7. Waldo SW, Hebbe A, Grunwald GK, Doll JA, Schofield R. Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Circ Cardiovasc Interv. 2021 01; 14(1):e009697.
    View in: PubMed
    Score: 0.449
  8. Waldo SW, Plomondon ME, O'Donnell CI, Heidenreich PA, Riatt MH, Ballard-Hernandez J, Ortiz J, Varosy PD, Vidovich MI, O'Donnell CJ, Schofield R. Trends in cardiovascular procedural volumes in the setting of COVID-19: Insights from the VA clinical assessment, reporting, and tracking program. Catheter Cardiovasc Interv. 2021 08 01; 98(2):E326-E328.
    View in: PubMed
    Score: 0.439
  9. Barrett C, Warsavage T, Kovach C, McGuinn E, Plomondon ME, Armstrong EJ, Waldo SW. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program. Catheter Cardiovasc Interv. 2021 02 01; 97(2):E219-E226.
    View in: PubMed
    Score: 0.431
  10. Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
    View in: PubMed
    Score: 0.417
  11. Doll JA, Plomondon ME, Waldo SW. Characteristics of the Quality Improvement Content of Cardiac Catheterization Peer Reviews in the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JAMA Netw Open. 2019 08 02; 2(8):e198393.
    View in: PubMed
    Score: 0.407
  12. Valle JA, Glorioso TJ, Bricker R, Bar?n AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program. JAMA Cardiol. 2019 08 01; 4(8):727-735.
    View in: PubMed
    Score: 0.407
  13. Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
    View in: PubMed
    Score: 0.400
  14. Bagai J, Hess E, Penny WF, Plomondon ME, Waldo SW. Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program. Cardiovasc Revasc Med. 2019 Nov; 20(11):990-996.
    View in: PubMed
    Score: 0.392
  15. Jawaid O, Stanislawski M, Bricker R, Plomondon ME, Grunwald GK, Valle JA, Armstrong EJ, Waldo SW. Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program. Coron Artery Dis. 2019 01; 30(1):44-50.
    View in: PubMed
    Score: 0.391
  16. Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary?Angiography and Percutaneous?Coronary?Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2018 05 14; 11(9):879-888.
    View in: PubMed
    Score: 0.374
  17. Armstrong EJ, Stanislawski MA, Kokkinidis DG, Plomondon ME, Bar?n AE, Giri J, Shunk KA, Banerjee S, Maddox TM, Waldo SW. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program. Catheter Cardiovasc Interv. 2018 05 01; 91(6):1009-1017.
    View in: PubMed
    Score: 0.355
  18. Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8.
    View in: PubMed
    Score: 0.325
  19. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention". Circulation. 2015 Sep 22; 132(12):e156.
    View in: PubMed
    Score: 0.312
  20. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23; 130(25):2295-301.
    View in: PubMed
    Score: 0.294
  21. Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
    View in: PubMed
    Score: 0.149
  22. Gonzalez PE, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon ME, Waldo SW, Pfau SE, Curtis JP, Shah SM. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program. Am J Cardiol. 2024 07 01; 222:39-50.
    View in: PubMed
    Score: 0.141
  23. Salahuddin T, Hebbe A, Daus M, Essien UR, Waldo SW, Rodriguez F, Ho PM, Simons C, Gilmartin HM, Doll JA. Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021. Am Heart J. 2024 02; 268:68-79.
    View in: PubMed
    Score: 0.137
  24. Kovach CP, Mesenbring EC, Gupta P, Glorioso TJ, Ho PM, Waldo SW, Schwartz GG. Projected Outcomes of Optimized Statin and Ezetimibe Therapy in US Military Veterans with Coronary Artery Disease. JAMA Netw Open. 2023 08 01; 6(8):e2329066.
    View in: PubMed
    Score: 0.134
  25. Parikh RV, Hebbe A, Bar?n AE, Grunwald GK, Plomondon ME, Gordin J, Yeh RW, Jneid H, Swaminathan RV, Waldo SW, Monto A, Secemsky E, Hsue PY. Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2023 02 21; 12(4):e028082.
    View in: PubMed
    Score: 0.130
  26. Chambers JW, Martinsen BJ, Sturm RC, Mandair D, Valle JA, Waldo SW, Guzzetta F, Armstrong EJ. Orbital atherectomy of calcified coronary ostial lesions. Catheter Cardiovasc Interv. 2022 10; 100(4):553-559.
    View in: PubMed
    Score: 0.126
  27. Tcheandjieu C, Zhu X, Hilliard AT, Clarke SL, Napolioni V, Ma S, Lee KM, Fang H, Chen F, Lu Y, Tsao NL, Raghavan S, Koyama S, Gorman BR, Vujkovic M, Klarin D, Levin MG, Sinnott-Armstrong N, Wojcik GL, Plomondon ME, Maddox TM, Waldo SW, Bick AG, Pyarajan S, Huang J, Song R, Ho YL, Buyske S, Kooperberg C, Haessler J, Loos RJF, Do R, Verbanck M, Chaudhary K, North KE, Avery CL, Graff M, Haiman CA, Le Marchand L, Wilkens LR, Bis JC, Leonard H, Shen B, Lange LA, Giri A, Dikilitas O, Kullo IJ, Stanaway IB, Jarvik GP, Gordon AS, Hebbring S, Namjou B, Kaufman KM, Ito K, Ishigaki K, Kamatani Y, Verma SS, Ritchie MD, Kember RL, Baras A, Lotta LA, Kathiresan S, Hauser ER, Miller DR, Lee JS, Saleheen D, Reaven PD, Cho K, Gaziano JM, Natarajan P, Huffman JE, Voight BF, Rader DJ, Chang KM, Lynch JA, Damrauer SM, Wilson PWF, Tang H, Sun YV, Tsao PS, O'Donnell CJ, Assimes TL. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nat Med. 2022 08; 28(8):1679-1692.
    View in: PubMed
    Score: 0.125
  28. Kini V, Parks M, Liu W, Waldo SW, Ho PM, Bradley SM, Hess PL. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 06 01; 5(6):e2217704.
    View in: PubMed
    Score: 0.124
  29. Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
    View in: PubMed
    Score: 0.122
  30. Nathan AS, Manandhar P, Wojdyla D, Nelson A, Fiorilli PN, Waldo S, Yeh RW, Rao SV, Fanaroff AC, Groeneveld PW, Wang TY, Giri J. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated?Risk Avoidance. J Am Coll Cardiol. 2021 11 30; 78(22):2213-2217.
    View in: PubMed
    Score: 0.120
  31. Brophy TJ, Warsavage TJ, Hebbe AL, Plomondon ME, Waldo SW, Rao SV, DeVore AD, Gutierrez JA, Swaminathan RV. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program. Am Heart J. 2021 05; 235:149-157.
    View in: PubMed
    Score: 0.113
  32. Prabhu KM, Don C, Sayre GG, Kearney KE, Hira RS, Waldo SW, Rao SV, Au DH, Doll JA. Interventional cardiologists' perceptions of percutaneous coronary intervention quality measurement and feedback. Am Heart J. 2021 05; 235:97-103.
    View in: PubMed
    Score: 0.113
  33. Kovach CP, Hebbe A, O'Donnell CI, Plomondon ME, Hess PL, Rahman A, Mulukutla S, Waldo SW, Valle JA. Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program). Am J Cardiol. 2021 05 01; 146:1-7.
    View in: PubMed
    Score: 0.113
  34. Sturm R, Armstrong EJ, Benhuri B, Okamoto N, Vengrenyuk Y, Shlofmitz E, Revtyak GE, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Aksut B, Bell S, Gardner R, Lee M, Zakir R, Shroff A, Don C, Shlofmitz R, Chambers JW, Kini A, Sharma S. Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter Analysis. Cardiovasc Revasc Med. 2021 05; 26:34-38.
    View in: PubMed
    Score: 0.111
  35. Sturm R, Martinsen BJ, Valle JA, Waldo SW, Behrens AN, Armstrong EJ. Orbital Atherectomy for Treatment of Complex Severely Calcified Coronary Artery Lesions: Insights from a Veterans Affairs Cohort. Cardiovasc Revasc Med. 2020 Mar; 21(3):330-333.
    View in: PubMed
    Score: 0.101
  36. Gutierrez JA, Bhatt DL, Banerjee S, Glorioso TJ, Josey KP, Swaminathan RV, Maddox TM, Armstrong EJ, Duvernoy C, Waldo SW, Rao SV. Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. Am Heart J. 2019 07; 213:47-56.
    View in: PubMed
    Score: 0.100
  37. Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, Kennedy KF, Masoudi FA, Yeh RW. Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative. JAMA Cardiol. 2019 02 01; 4(2):100-109.
    View in: PubMed
    Score: 0.098
  38. Hu PT, Jones WS, Glorioso TJ, Bar?n AE, Grunwald GK, Waldo SW, Maddox TM, Vidovich M, Banerjee S, Rao SV. Predictors and Outcomes of Staged?Versus One-Time Multivessel?Revascularization in Multivessel?Coronary?Artery Disease: Insights From the VA CART Program. JACC Cardiovasc Interv. 2018 11 26; 11(22):2265-2273.
    View in: PubMed
    Score: 0.097
  39. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.096
  40. Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018 08 01; 92(2):285-299.
    View in: PubMed
    Score: 0.090
  41. Kobayashi T, Glorioso TJ, Armstrong EJ, Maddox TM, Plomondon ME, Grunwald GK, Bradley SM, Tsai TT, Waldo SW, Rao SV, Banerjee S, Nallamothu BK, Bhatt DL, Rene AG, Wilensky RL, Groeneveld PW, Giri J. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. JAMA Cardiol. 2017 09 01; 2(9):967-975.
    View in: PubMed
    Score: 0.089
  42. Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
    View in: PubMed
    Score: 0.086
  43. Chen DC, Singh GD, Armstrong EJ, Waldo SW, Laird JR, Amsterdam EA. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease. Am J Cardiol. 2017 Apr 15; 119(8):1146-1152.
    View in: PubMed
    Score: 0.086
  44. Turner TE, Waldo SW, Kulkarni A, Armstrong EJ, Hoffmayer KS, Kinlay S, Hsue P, Ganz P, McCabe JM. Long-term outcomes of patients sent emergently to the catheterization laboratory for possible primary percutaneous coronary intervention. Am J Cardiol. 2013 Dec 01; 112(11):1745-9.
    View in: PubMed
    Score: 0.068
  45. Armstrong EJ, Graham L, Waldo SW, Valle JA, Maddox TM, Hawn MT. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):617-627.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)